🇺🇸 FDA
Pipeline program

Linaclotide or Matching Placebo

MCP-103-302

Phase 3 small_molecule completed

Quick answer

Linaclotide or Matching Placebo for Irritable Bowel Syndrome With Constipation is a Phase 3 program (small_molecule) at IRONWOOD PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).

Program details

Company
IRONWOOD PHARMACEUTICALS INC
Indication
Irritable Bowel Syndrome With Constipation
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials